PRESS RELEASES

All Releases
Apr 25, 2017
AUSTIN, Texas, April 25, 2017 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) today reported financial results for the first quarter (Q1) of 2017.  Net loss was $2.7 million, or $0.06 per share, for the three months ended March 31, 2017, compared to a net loss of $5.8 million, or
Feb 17, 2017
AUSTIN, Texas, Feb. 17, 2017 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) today reported financial results for the year ended December 31, 2016 and provided an update on recent developments.  Net loss in 2016 was $14.9 million, or $0.33 per share, compared to a net loss in 2015 of
Oct 20, 2016
AUSTIN, Texas, Oct. 20, 2016 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) today reported financial results for the third quarter of 2016.  Net loss in Q3 2016 was $3.5 million, or $0.08 per share, compared to a net loss in Q3 2015 of $3.7 million, or $0.08 per share.
Sep 26, 2016

Company Will Host Conference Call Monday, September 26th at 9:00am EDT

Jul 19, 2016
AUSTIN, Texas, July 19, 2016 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) today reported financial results for the second quarter of 2016.  Net loss in Q2 2016 was $3.0 million, or $0.07 per share, compared to a net loss in Q2 2015 of $3.4 million, or $0.07 per share.
May 19, 2016
- August 5 th is FDA's Tentative Date for Advisory Committee Meeting - - No Change to PDUFA Date - AUSTIN, Texas, May 19, 2016 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) announced today that an Advisory Committee of the U.S. Food and Drug Administration (FDA) will review the REMOXY
May 11, 2016
AUSTIN, Texas, May 11, 2016 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) today announced that researchers will present new data around REMOXY's abuse-deterrent properties at the 35 th Annual Scientific Meeting of the American Pain Society (APS), held this year in Austin, TX.